Target intelligence / Profile preview

Klotho Beta (KLB)

Target
KLB
Molecular classification
Single-pass transmembrane protein, Glycoside hydrolase family 1 superfamily, Co-receptor
01

Overview

Klotho beta (KLB) is a single-pass transmembrane protein that functions as an obligatory co-receptor for the endocrine fibroblast growth factors FGF19 and FGF21. It plays a critical role in regulating bile acid synthesis, glucose homeostasis, lipid metabolism, and energy expenditure. KLB primarily acts by forming complexes with FGFRs upon binding with FGF19 or FGF21, triggering downstream signaling cascades. Its involvement in metabolic regulation makes it a potential therapeutic target, with mimetics of its ligands showing promise in clinical trials.

Other names
KLOTBBeta-Klotho
02

Mechanism of action

KLB acts as an essential co-receptor for certain endocrine fibroblast growth factors, notably FGF19 and FGF21, facilitating their binding to FGFRs and subsequent downstream signaling involved in metabolic regulation.

03

Biological functions

FGF receptor bindingRegulation of bile acid synthesisModulation of glucose homeostasisModulation of lipid metabolismRegulation of energy expenditureSignal transduction
04

Disease associations

Hypogonadotropic hypogonadismMale infertilityFunctional diarrheaMetabolic disorders
05

Safety considerations

Potential for off-target effects due to broad tissue expressionLong-term effects of modulating FGF signaling pathways

Beyond the preview

Go deeper on Klotho Beta (KLB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klotho Beta (KLB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call